Search Results 501-510 of 91061 for Metastasis

  1. Stage 4 (metastatic) colon cancer - Doctors and departments - Mayo Clinic

    ... metastases. Stage 4 (metastatic) colon cancer. Symptoms & causes · Diagnosis & treatment · Doctors & departments · Care at. Mayo Clinic. Research: It's all ...

  2. Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer - Mayo Clinic

    Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer · Overview.

  3. Mayo research shows surgery adds years for kidney cancer patients

    “The research found patients who had surgery to remove metastases were about half as likely to have died from their metastatic disease at every point in time ...

  4. Publications - Dan S. Childs, M.D. - Mayo Clinic

    Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu-PSMA-617. J Nucl Med. 2024 Dec 03; 65(12): ...

  5. Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - Mayo Clinic

    The purpose of this study is evaluate the efficacy of INCB054828 in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 ...

  6. Neurology - Clinical trials

    Whole brain radiotherapy (WBRT) is the most common treatment for brain metastasis. Unfortunately, the majority of patients with brain metastases experience ...

  7. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR ...

  8. Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases - Mayo Clinic

    ... metastases). Participation eligibility. Participant eligibility includes age ... - More than one brain metastasis planned for resection. - Inability to ...

  9. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

    Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic ...

  10. CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin - Mayo Clinic

    This study evaluates the combination of CBT-1® and doxorubicin for the treatment of metastatic, unresectable sarcoma in patients who have progressed after ...